Press Releases

 Filter by Provider

New York, NY - January 12, 2026 - Glamdring Research has published its 2026 research report, “Creator Monetization Platform Trends 2026: What’s Next,” analyzing how monetization platforms are evolving as creators build more durable, business-like digital enterprises. Unlike evaluations that focus on surface-level features, the report assesses platforms by structural criteria such as ownership of customer relationships, monetization architecture, economic models, and long-term risk exposure.

Rocket Languages is an online platform created for people who want to learn a new language. It focuses on helping you learn the language from the basics so that you can speak confidently, understand native speakers, and feel comfortable using the language in real life. The platform has been around for more than 22 years, which already shows that it is experienced and reliable. It has helped more than two million people around the world, and this makes it feel like a safe and trusted choice for beginners and serious learners. It is reliable, easy, and truly helpful. Online Language Courses Designed By Language Lovers, Crafted For You

New York, NY - January 12, 2026 - Glamdring Research has released a new industry report, “Creator Monetization Platform Trends 2026: What’s Next,” examining how creator platforms are evolving as the creator economy enters a more mature and infrastructure-driven phase.

VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability

Cambridge, Massachusetts--(Newsfile Corp. - January 12, 2026) - DaCapo Brainscience today announced the appointment...

Logistic Properties of the Americas (NYSE American: LPA) (together with its subsidiaries, "LPA" or the "Company"), announced today the execution of a long-term lease with a major regional packaging company that will be an anchor tenant for Building 400, the construction of which has begun at Parque Logístico Callao, one of Peru’s most strategically located logistics parks.

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the fourth quarter and full year ended December 31, 2025.

BioMed Realty, the largest privately-owned operator of real estate for the life science and technology industries, and TransMedics Group, Inc. (“TransMedics”, ticker: TMDX), a publicly traded medical technology company transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that TransMedics has entered into a full building, 498,000-square-foot lease at Assembly Innovation Park, a premier life sciences development in Somerville, Massachusetts developed by BioMed Realty.

HONESDALE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Norwood Financial Corp (Nasdaq Global Market-NWFL) and its subsidiary, Wayne Bank, will release its fourth quarter 2025 financial results before market opens on Thursday, January 22, 2026. On the same day, the Company will host a webcast and conference call at 9:00 a.m. ET to discuss the financial results.

Anumana Inc., a leader in AI-powered cardiovascular detection algorithms, today announced the appointment of Kevin Ballinger and Jean-Luc Butel to its Board of Directors. In their roles, Ballinger and Butel will provide strategic guidance to Anumana’s leadership team as the company advances its AI-driven capabilities, expands clinical adoption, and scales operations.

Aspen Power, a leading distributed generation platform backed by Carlyle and dedicated to building the clean energy future, today announced the successful closing of a $200 million capital raise provided by Deutsche Bank. The new capital commitment will bolster Aspen Power’s financial capacity and support growth initiatives across development, vendor engagement, and project deployment as it scales its platform nationwide.

Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026.

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenue for Q4 and full year 2025 of approximately $243 million and $868 million, respectively. The company continues to build on six consecutive years of revenue growth. On track to extend the pitolisant franchise, Harmony fortifies its profile as a profitable, self-funding biotech company with a robust, late-stage pipeline and strong long-term growth potential. Harmony will highlight its commercial performance and pipeline advancements at its presentation at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 4:30 p.m. PT / 7:30 p.m. ET in San Francisco, CA.

Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity verification and fraud prevention, has been recognized for its strong performance in a recent independent evaluation by Datos Insights, a respected financial services research and advisory firm.

Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic and infectious diseases, today announced corporate, financial, and pipeline updates in advance of its participation at the 2026 J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco. Throughout the conference, Turn Therapeutics will participate in investor and partner meetings to discuss the Company's clinical progress, expanding pipeline, capital position, and anticipated 2026 milestones.

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, and CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, today announced a clinical collaboration to conduct a Phase 1 trial in China, planned to begin in 2026.

Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024

ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today provided a preliminary update on financial results for the fourth quarter and full year ended December 31, 2025.

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reiterated the full year 2025 guidance of $293 million to $299 million with positive GAAP operating income and initiated the full year 2026 guidance.

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that it has completed an equity financing led by institutional investors -- including Access Biotechnology, Alexandria Venture Investments, NEA and Westlake BioPartners – alongside a strategic investment by Lilly.

Completed Business Combination

Becomes Largest Missouri C-PACE loan to date

As 12K Americans reach retirement age daily, the availability of stable long-term income solutions is growing

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s October 2025 initial public offering (“IPO” or the “Offering”); and/or (b) securities between October 1, 2025 and December 11, 2025, inclusive (the “Class Period”).

$7.53M gross proceeds raised from pre-existing investors, providing capital runway into 2027All nine investors that were offered agreed to participateNet...

Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ETX101 for the treatment of SCN1A+ Dravet syndrome. This designation is in addition to Regenerative Medicine Advanced Therapy (RMAT), Fast Track, Orphan Drug, and Rare Pediatric Disease Designations, all previously granted by the FDA.

Fairbanks Morse Defense (FMD) has announced the expansion of its robotic welding program aimed at boosting ship repair and maintenance efficiency for the U.S. Navy and allied fleets. The company’s robotic welding technology combines automation, precision and data-driven performance to reduce operational downtime, improve safety and extend the service life of naval assets.

Junevity, a biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, today announced the publication of a peer-reviewed study in Proceedings of the National Academy of Sciences (PNAS) validating that precise modulation of individual transcription factors can reverse core hallmarks of cellular aging and restore tissue function in vivo. The paper covers systemic identification of transcription factors for cell and tissue rejuvenation. The findings form the scientific foundation for Junevity’s RESET platform and longevity-focused therapeutic programs, including JUN_01, the company’s lead siRNA (silencing RNA) candidate for type 2 diabetes and obesity.

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year.

CINCINNATI, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Vortex Doors, a nationwide leader in commercial door repair, maintenance, and replacement, is excited to announce the grand opening of its new service center in Cincinnati, Ohio. This expansion allows Vortex to bring fast, reliable, and agnostic door and loading dock equipment services to businesses throughout Cincinnati, the greater Ohio area, and beyond.

SPRING, TX - January 12, 2026 - In an industry dominated by crowded salons and rushed appointments, Polished by Kim is redefining the nail care experience with a unique private studio model that puts clients first. Located conveniently off Interstate 45 near Research Forest Drive, the boutique nail studio serves residents of The Woodlands, Cochran's Crossing, Lake Woodlands Crossing, and surrounding communities with an exclusive one-on-one appointment structure.Unlike traditional nail salons where multiple clients are serviced simultaneously in a bustling environment, Polished by Kim operates on a revolutionary private appointment model.

SAN BERNARDINO, CALIFORNIA / ACCESS Newswire / January 12, 2026 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) (Dateline or the Company) is pleased to announce drilling results at its 100%-owned Colosseum Gold and Rare Earth Element (REE) Project in San Bernardino County, California. The results from a further six diamond and ten reverse circulation (RC) holes drilled around the South and North Pits have provided gold assay results that improve the continuity of mineralisation and in several instances, deliver results outside the mineral resource envelope.

NEW YORK CITY, NY / ACCESS Newswire / January 12, 2026 / Classover Holdings Inc. (Nasdaq:KIDZ)(Nasdaq:KIDZW) ("Classover" or the "Company"), a leading provider in K-12 educational AI, today announced a new round of core product upgrades for its Real-Time AI Tutor developed in collaboration with MiniMax, further strengthening an AI-native, near-human interactive learning experience and improving readiness for scaled deployment.

ANAHEIM, CA / ACCESS Newswire / January 12, 2026 / Phoenix Motor Inc. (OTC:PEVM) ("PhoenixEV" or the "Company"), leader in zero-emission commercial transportation, today announced that the United States Patent and Trademark Office has issued a new U.S. utility patent covering cutting edge low-floor electric bus architecture and integrated battery system design. The newly issued patent, U.S. Patent No. 12,508,890, strengthens Phoenix Motor's intellectual property portfolio and reinforces the company's leadership in heavy-duty electric vehicle innovation.

WARREN, ID / ACCESS Newswire / January 12, 2026 / Sidney Resources Corporation (OTCID:SDRC) ("Sidney" or the "Company") is pleased to report a significant metallurgical milestone achieved through ongoing processing and testing at its Warren District project in Idaho. Recent work has successfully produced metallic smelter "buttons" containing iridium, marking a key technical advancement in the Company's polymetallic development program.

HONG KONG, HK / ACCESS Newswire / January 12, 2026 / GapaSea proudly introduces its latest outdoor wearable: GapaSea Walkie-Talkie Glasses - a hands-free communication solution that combines walkie-talkie, open-ear headphones, and sport sunglasses into a single, lightweight frame. Designed for outdoor adventures and team activities, GapaSea keeps you connected when phones and networks fall short.

In constantly changing market and labor conditions, retailers are struggling to understand ever changing patterns of customer behavior, inventory costs and supply, and labor access. Human analysts simply can't keep up because even if they look at a chart a minute, they can only evaluate less than 500 patterns a day. Aible's automated analysis agents look at millions of patterns across billions of sales transactions to highlight the key actionable insights.

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided additional details for its upcoming Investor Day, scheduled for Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City. The Investor Day will be both in-person and available to view via webcast.

LEXINGTON, KY / ACCESS Newswire / January 12, 2026 / Cardiff Lexington Corporation (OTCQB:CDIX) ("Cardiff" or the "Company"), a healthcare holding company with deep leadership and operational expertise in Orthopedics, Spine Care, and Pain Management, today announced a 1-for-3 reverse stock split of its issued and outstanding common stock, par value $0.001 per share (the "Reverse Stock Split"), which became effective as of 12:01 a.m. Eastern Time on January 12, 2026. Each 3 shares of the issued and outstanding Common Stock shall be reclassified and combined into 1 share of Common Stock (the "Reverse Split"). No fractional shares shall be issued in connection with the Reverse Split. Any fractional share that would otherwise be issued shall be rounded up to the next whole share. The Company's common stock continues to trade on The OTCQB Venture Market under the symbol "CDIX" and is expected to begin trading on a split-adjusted basis on the OTCQB Venture Market at the commencement of trading today. Following the Reverse Stock Split, the Company's ticker symbol will be CDIXD for 20 trading days including the effective date.

BOCA RATON, FL / ACCESS Newswire / January 12, 2026 / For years, investors were trained to believe the bottleneck in artificial intelligence would be chips. Then it was talent. Then it was data. Each time, the market adjusted, capital flowed, and new winners emerged. What has changed quietly, but decisively, is where that constraint now lives.

TORONTO, ON / ACCESS Newswire / January 12, 2026 / Endeavour Solutions Inc. is proud to announce its rebrand as Endeavor4, marking a significant milestone in our journey to deliver everyday excellence for clients across North America. This transformation brings together Endeavour Solutions, Purely CRM, Express Info, Corterra Solutions, and other recent acquisitions under one unified brand-reflecting our continued commitment to client success and innovation.

Experts emphasize individualized care as demand grows for solutions to facial volume loss and loose skin following medical weight reduction.

GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillment, today announced a comprehensive strategic realignment to address the critical infrastructure gap in the global distribution of GLP-1 (glucagon-like peptide-1) medications.

Many IRS installment agreements fail not because of missed payments, but because taxpayers overlook ongoing compliance rules that can quietly trigger default and renewed collections.

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - Riverside Resources Inc. (TSXV: RRI) (OTCQB: RVSDF) (FSE: 5YY0) ("Riverside" or the "Company"),...

The Venture Capital & Private Equity Club, the largest student club at Harvard Business School, will hold the 32nd annual VCPE Conference on Saturday, January 31, 2026, on the Harvard Business School campus in Boston.

Pagaya Technologies Ltd. (“Pagaya” or the “Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced that the Company’s management team will participate in the following investor conferences:

First Manhattan, a $36B+ independently owned investment advisory firm, today announced that Adam Yale has joined as Portfolio Manager, returning to where he began his professional career more than 25 years ago.

Sleep Number Corporation (Nasdaq: SNBR) today announces its newest product, ComfortMode, its most comfortable mattress at a sub-$1,600 price point. ComfortMode delivers ultimate comfort with no app or connectivity required. The new bed is simple to operate, without compromising on the innovations consumers know and expect from Sleep Number, including firmness adjustability and temperature balancing benefits. Sleep Number is also launching a new adjustable base, designed to fit any bed frame, giving consumers the benefits of head and foot adjustability within their existing furniture.

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue for IBTROZI® (taletrectinib) and provided a 2026 outlook ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.